Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 1473 Records) |
Query Trace: Brca[original query] |
---|
Hereditary Breast Cancer in Romania-Molecular Particularities and Genetic Counseling Challenges in an Eastern European Country. Biomedicines 2023 5 11 (5): . Andreea C?tan?, Adrian P Trifa, Patriciu A Achimas-Cadariu, Gabriela Bolba-Morar, Carmen Lisencu, Eniko Kutasi, Vlad F Chelaru, Maximilian Muntean, Daniela L Martin, Nicoleta Z Antone, Bogdan Fetica, Florina Pop, Mariela S Milita |
Comparison of PARPi efficacy according to homologous recombination deficiency biomarkers in patients with ovarian cancer: a systematic review and meta-analysis. Chinese clinical oncology 2023 5 . Felipe Batalini, Laercio Lopes DaSilva, Leticia Campoverde, Ana Carolina Marin Comini, Bruno Murad Carvalho, Wilson Nogueira, Hyan Silveira, Brenda J Ernst, Lida A Mi |
Role of PARP inhibitors beyond BRCA mutation and platinum sensitivity in epithelial ovarian cancer: a meta-analysis of hazard ratios from randomized clinical trials. World journal of surgical oncology 2023 5 21 (1): 157. Roli Purwar, Rakesh Ranjan, Manjusha Pal, Satyanshu K Upadhyay, Tarun Kumar, Manoj Pand |
Multigene germline testing usefulness instead of BRCA1/2 single screening in triple negative breast cancer cases. Pathology, research and practice 2023 5 247 154514. M Arranz-Ledo, E Lastra, L Abella, R Ferreira, M Orozco, L Hernández, N Martínez, M Infante, M Dur |
Incidence of Cancer and Role of Sentinel Lymph Node Biopsy in BRCA Mutation Carriers Undergoing Prophylactic Mastectomies. The American surgeon 2023 5 31348231175498. Shelby Chun Fat, Christina Weed, Yasmina Samaha, Alice Chung, Marissa K Boyle, Armando Giuliano, Edward Ray, Farin Amer |
Mutations in Homologous Recombination Genes and Loss of Heterozygosity Status in Advanced-Stage Breast Carcinoma. Cancers 2023 5 15 (9): . Brooke B Bartow, Gene P Siegal, Ceren Yalniz, Ahmed M Elkhanany, Lei Huo, Qingqing Ding, Aysegul A Sahin, Hua Guo, Cristina Magi-Galluzzi, Shuko Harada, Xiao Hua |
Frequency of Germline and Somatic BRCA1 and BRCA2 Mutations in Prostate Cancer: An Updated Systematic Review and Meta-Analysis. Cancers 2023 5 15 (9): . Anna Amela Valsecchi, Rossana Dionisio, Olimpia Panepinto, Jessica Paparo, Andrea Palicelli, Francesca Vignani, Massimo Di Ma |
Maintenance olaparib in patients with platinum-sensitive relapsed ovarian cancer: Outcomes by somatic and germline BRCA and other homologous recombination repair gene mutation status in the ORZORA trial. Gynecologic oncology 2023 4 172 121-129. Pignata Sandro, Oza Amit, Hall Geoff, Pardo Beatriz, Madry Radoslaw, Cibula David, Klat Jaroslav, Montes Ana, Glasspool Rosalind, Colombo Nicoletta, Pete Imre, Herrero Ibáñez Ana, Marín Margarita Romeo, Ilieva Rumyana, Timcheva Constanta, Di Maio Massimo, Blakeley Christopher, Taylor Rosie, Barnicle Alan, Clamp Andr |
A study of somatic BRCA variants and their putative effect on protein properties in malignant mesothelioma. Pleura and peritoneum 2023 4 8 (1): 19-25. Krishnamurthy Kritika, Oh Kei Shing, Alghamdi Sarah, Sriganeshan Vathany, Poppiti Robe |
ASO Visual Abstract: Oncologic Safety of Nipple-Sparing Mastectomy for Breast Cancer in BRCA Gene Mutation Carriers-Outcomes at 70 Months Median Follow-up. Annals of surgical oncology 2023 4 . Webster Alexandra J, Shanno Julia N, Cruz Heidi S Santa, Kelly Bridget N, Garstka Meghan, Henriquez Anthony, Specht Michelle C, Gadd Michele A, Verdial Francys C, Nguyen Anvy, Oseni Tawakalitu O, Coopey Suzanne B, Smith Barbara |
Treatment of women with BRCA mutation. Climacteric : the journal of the International Menopause Society 2023 4 1-5. Depypere |
Genetic Characterization of Ovarian Tumor Tissues from Patients with Epithelial Ovarian Cancer in a Philippine Tertiary Hospital: A Descriptive Study. Asian Pacific journal of cancer prevention : APJCP 2023 4 24 (4): 1187-1197. Ryan C V Lintao, Ana Joy P Padua, Yukiko Nakura, Erlidia F Llamas-Clark, Itaru Yanagiha |
Impact of Breast Cancer and Germline BRCA Pathogenic Variants on Fertility Preservation in Young Women. Life (Basel, Switzerland) 2023 4 13 (4): . Elze Prokurotaite, Margherita Condorelli, Julie Dechene, Jason Bouziotis, Matteo Lambertini, Isabelle Demeeste |
What is the appropriate genetic testing criteria for breast cancer in the Chinese population?-Analysis of genetic and clinical features from a single cancer center database. Cancer medicine 2023 4 . Mengqian Ni, Fang Wang, Anli Yang, Qiong Shao, Cong Xue, Wen Xia, Fei Xu, Xi Lin, Jiajia Huang, Xiwen Bi, Ruoxi Hong, Meiting Chen, Qiufan Zheng, Kuikui Jiang, Xinhua Xie, Jun Tang, Xi Wang, Zhongyu Yuan, Shusen Wang, Yanxia Shi, Xin |
miRNA deregulation and relationship with metabolic parameters after Mediterranean dietary intervention in BRCA-mutated women. Frontiers in oncology 2023 4 13 1147190. Simona De Summa, Debora Traversa, Antonella Daniele, Orazio Palumbo, Massimo Carella, Raffaella Stallone, Antonio Tufaro, Andreina Oliverio, Eleonora Bruno, Maria Digennaro, Katia Danza, Patrizia Pasanisi, Stefania Tomma |
The pathogenic role of the BRCA2 c.7847C>T (p.Ser2616Phe) variant in breast and ovarian cancer predisposition. Cancer science 2023 4 . Yamazawa Kazuki, Sugano Kokichi, Tanakaya Kohji, Inoue Satomi, Murakami Haruka, Nakashima Moeko, Adachi Masataka, Oki Shinya, Makabe Takeshi, Yamashita Hiroshi, Ueki Arisa, Sasaoka Ayako, Nakashoji Ayako, Kinoshita Takayuki, Matsunaga Tatsuo, Arai Masami, Nakamura Seigo, Miyata Hiroaki, Ikegami Masachika, Mano Hiroyuki, Kohsaka Shinji, Matsui Aki |
Clinical relevance of BRCA1 promoter methylation testing in ovarian cancer patients. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 4 . Blanc-Durand Félix, Tang Roseline, Pommier Margaux, Nashvi Marzieh, Cotteret Sophie, Genestie Catherine, Le Formal Audrey, Pautier Patricia, Michels Judith, Kfoury Maria, Hervé Robert, Mengue Sylvie, Wafo Estelle, Elies Antoine, Miailhe Gregoire, Uzan Jennifer, Rouleau Etienne, Leary Alexand |
Investigation of poly ADP-ribose polymerase inhibitor resistance based on serially collected circulating tumor DNA in patients with BRCA-mutated ovarian cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 4 . Kim Yoo-Na, Shim Yeeun, Seo Jieun, Choi Zisun, Lee Yong Jae, Shin Saeam, Kim Sang Wun, Kim Sunghoon, Choi Jong Rak, Lee Jung-Yun, Lee Seung-T |
Increased prevalence of the founder BRCA1 c.5309G>T and recurrent BRCA2 c.1310_1313delAAGA mutations in breast cancer families from Northerstern region of Morocco: evidence of geographical specificity and high relevance for genetic counseling. BMC cancer 2023 4 23 (1): 339. Melki Rahma, Melloul Marouane, Aissaoui Souria, El Harroudi Tijani, Boukhatem Noureddi |
A Brand New BRCA-CRisk Model Precisely Predicts the Prognosis of Patients With Breast Cancer and BRCA1/2 Mutation. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2023 4 JCO2202893. Zhao Yu-Fei, Du Jun-Xian, Zhu W |
Exceptional responses to PARP inhibitors in patients with metastatic breast cancer in oncologic crisis. Breast cancer research and treatment 2023 3 1-9. Cheng Joyce M, Canzoniero Jenna, Lee Seoho, Soni Sudeep, Mangini Neha, Santa-Maria Cesar |
Germline mutations in homologous recombination repair genes among Chinese pancreatic ductal adenocarcinoma patients detected using next-generation sequencing. Molecular genetics & genomic medicine 2023 3 e2170. Jiang Huiqin, Huang Fei, Chen Xinning, Zhang Li, Shen Minna, Pan Baishen, Wang Beili, Guo W |
Olaparib efficacy in patients with germline BRCA-mutated, HER2-negative metastatic breast cancer: subgroup analyses from the phase III OlympiAD trial. International journal of cancer 2023 3 . Senkus El?bieta, Delaloge Suzette, Domchek Susan M, Conte Pierfranco, Im Seock-Ah, Xu Binghe, Armstrong Anne, Masuda Norikazu, Fielding Anitra, Robson Mark, Tung Nadi |
DOSE-RESPONSE RELATIONSHIPS BETWEEN CIGARETTE SMOKING AND BREAST CANCER RISK: A SYSTEMATIC REVIEW AND META-ANALYSIS. Journal of epidemiology 2023 3 . Scala Marco, Bosetti Cristina, Bagnardi Vincenzo, Possenti Irene, Specchia Claudia, Gallus Silvano, Lugo Alessand |
Characteristics, Treatment, and Outcomes of Real-World Talazoparib-Treated Patients With Germline BRCA-Mutated Advanced HER2-Negative Breast Cancer. The oncologist 2023 3 . Zimmerman Savill Kristin M, Ivanova Jasmina, Asgarisabet Parisa, Falkenstein Angelica, Balanean Alexandrina, Niyazov Alexander, Ryan Joanne C, Kish Jonathan, Gajra Ajeet, Mahtani Reshma |
Impact of multifocal or multicentric disease on local recurrence and survival in breast cancer patients with or without BRCA1/2 variants. Breast cancer research and treatment 2023 3 . Liu Xuejing, Wang Yanjie, Cao Kun, Yao Lu, Hu Li, Sun Jie, Zhang Juan, Xu Ye, Xie Yunt |
Homologous recombination deficiency status predicts response to platinum-based chemotherapy in Chinese patients with high-grade serous ovarian carcinoma. Journal of ovarian research 2023 3 16 (1): 53. Feng Zheng, Shao Di, Cai Yuhang, Bi Rui, Ju Xingzhu, Chen Dongju, Song Chengcheng, Chen Xiaojun, Li Jin, An Na, Li Yunjin, Zhou Qing, Xiu Zhihui, Zhu Shida, Wu Xiaohua, Wen H |
Characterization of patients with a diagnosis of breast cancer and melanoma: genetic susceptibility or increased surveillance? European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2023 3 . Jia Karen Y, Menes Tehillah S, Bernstein-Molho Rinat, Nissan Aviram, Zippel D |
Exploration of prognostic genes and risk signature in breast cancer patients based on RNA binding proteins associated with ferroptosis. Frontiers in genetics 2023 3 14 1025163. Chen Xiang, Yang Changcheng, Wang Wei, He Xionghui, Sun Hening, Lyu Wenzhi, Zou Kejian, Fang Shuo, Dai Zhijun, Dong Huayi |
Efficacy and safety of PARP inhibitors in the treatment of BRCA-mutated breast cancer: an updated systematic review and meta-analysis of randomized controlled trials. Expert review of clinical pharmacology 2023 3 16 (3): 245-256. Sun Xiaoyu, Xu Suying, Li Yiming, Lv Xuemei, Wei Minjie, He Mi |
- Page last reviewed:Feb 1, 2023
- Page last updated:Jun 02, 2023
- Content source: